Andrew Mok
Stock Analyst at Barclays
(2.34)
# 2,515
Out of 4,732 analysts
136
Total ratings
41.84%
Success rate
-0.8%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Overweight | $655 → $642 | $509.76 | +25.94% | 6 | Jan 17, 2025 | |
| CNC Centene | Maintains: Overweight | $91 → $93 | $62.25 | +49.40% | 6 | Dec 13, 2024 | |
| RDNT RadNet | Maintains: Overweight | $79 → $85 | $59.86 | +42.00% | 5 | Dec 4, 2024 | |
| ACHC Acadia Healthcare Company | Maintains: Overweight | $76 → $43 | $43.78 | -1.78% | 11 | Nov 22, 2024 | |
| AGL agilon health | Maintains: Underweight | $5 → $2 | $3.09 | -35.28% | 2 | Nov 11, 2024 | |
| THC Tenet Healthcare | Maintains: Overweight | $171 → $190 | $130.86 | +45.19% | 10 | Nov 8, 2024 | |
| HCA HCA Healthcare | Maintains: Overweight | $396 → $392 | $310.45 | +26.27% | 8 | Nov 8, 2024 | |
| PRVA Privia Health Group | Maintains: Equal-Weight | $19 → $21 | $22.24 | -5.58% | 6 | Nov 8, 2024 | |
| CVS CVS Health | Maintains: Overweight | $75 → $71 | $52.62 | +34.93% | 6 | Nov 7, 2024 | |
| CI The Cigna Group | Maintains: Overweight | $405 → $420 | $283.99 | +47.89% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $250 → $253 | $282.63 | -10.48% | 5 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $150 → $164 | $166.24 | -1.35% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $7 → $8 | $14.58 | -45.13% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $109 → $116 | $94.74 | +22.44% | 13 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $256 → $271 | $184.80 | +46.65% | 20 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $359 → $372 | $286.21 | +29.97% | 3 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $3 → $5 | $3.06 | +63.40% | 4 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $622 → $501 | $385.29 | +30.03% | 5 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $88 → $83 | $133.87 | -38.00% | 2 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $35 | $20.19 | +73.35% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $7.99 | +50.19% | 1 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $145 → $95 | $91.91 | +3.36% | 7 | Aug 2, 2022 |
UnitedHealth Group
Jan 17, 2025
Maintains: Overweight
Price Target: $655 → $642
Current: $509.76
Upside: +25.94%
Centene
Dec 13, 2024
Maintains: Overweight
Price Target: $91 → $93
Current: $62.25
Upside: +49.40%
RadNet
Dec 4, 2024
Maintains: Overweight
Price Target: $79 → $85
Current: $59.86
Upside: +42.00%
Acadia Healthcare Company
Nov 22, 2024
Maintains: Overweight
Price Target: $76 → $43
Current: $43.78
Upside: -1.78%
agilon health
Nov 11, 2024
Maintains: Underweight
Price Target: $5 → $2
Current: $3.09
Upside: -35.28%
Tenet Healthcare
Nov 8, 2024
Maintains: Overweight
Price Target: $171 → $190
Current: $130.86
Upside: +45.19%
HCA Healthcare
Nov 8, 2024
Maintains: Overweight
Price Target: $396 → $392
Current: $310.45
Upside: +26.27%
Privia Health Group
Nov 8, 2024
Maintains: Equal-Weight
Price Target: $19 → $21
Current: $22.24
Upside: -5.58%
CVS Health
Nov 7, 2024
Maintains: Overweight
Price Target: $75 → $71
Current: $52.62
Upside: +34.93%
The Cigna Group
Nov 5, 2024
Maintains: Overweight
Price Target: $405 → $420
Current: $283.99
Upside: +47.89%
Oct 31, 2024
Maintains: Equal-Weight
Price Target: $250 → $253
Current: $282.63
Upside: -10.48%
Oct 31, 2024
Maintains: Equal-Weight
Price Target: $150 → $164
Current: $166.24
Upside: -1.35%
Oct 30, 2024
Maintains: Underweight
Price Target: $7 → $8
Current: $14.58
Upside: -45.13%
Oct 29, 2024
Maintains: Overweight
Price Target: $109 → $116
Current: $94.74
Upside: +22.44%
Oct 25, 2024
Maintains: Overweight
Price Target: $256 → $271
Current: $184.80
Upside: +46.65%
Oct 25, 2024
Maintains: Equal-Weight
Price Target: $359 → $372
Current: $286.21
Upside: +29.97%
Oct 24, 2024
Maintains: Equal-Weight
Price Target: $3 → $5
Current: $3.06
Upside: +63.40%
Oct 22, 2024
Maintains: Overweight
Price Target: $622 → $501
Current: $385.29
Upside: +30.03%
Apr 23, 2024
Downgrades: Underweight
Price Target: $88 → $83
Current: $133.87
Upside: -38.00%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $35
Current: $20.19
Upside: +73.35%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $7.99
Upside: +50.19%
Aug 2, 2022
Downgrades: Sell
Price Target: $145 → $95
Current: $91.91
Upside: +3.36%